Skip to main content

Schiff Andrew N

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Schiff Andrew N as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACRS Aclaris Therapeutics, Inc.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 21, 2022 (view filing)Jun 174 daysSchiff Andrew NDirectorSSale−19.6K$15.14−$296.2K−100.0%0 after
Oct 6, 2022 (view filing)Oct 4-62 daysSchiff Andrew NDirectorSSale−45.5K$16.45−$749.1K−7.2%588.9K after2 lots
Oct 11, 2022 (view filing)Oct 74 daysSchiff Andrew NDirectorSSale−7.32K$16.16−$118.4K−1.2%581.6K after
Oct 19, 2022 (view filing)Oct 17-182 daysSchiff Andrew NDirectorSSale−52.0K$16.57−$862.2K−8.9%529.6K after2 lots
Oct 26, 2022 (view filing)Oct 24-262 daysSchiff Andrew NDirectorSSale−41.2K$17.01−$700.5K−7.8%488.4K after3 lots
Nov 14, 2022 (view filing)Nov 10-144 daysSchiff Andrew NDirectorSSale−53.9K$17.05−$919.5K−11.0%434.5K after3 lots

Elevation Oncology, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2021 (view filing)6:29 PM ETJun 292 daysElms Steve and 4 othersDirector, Other: Managing MemberPPurchase+187.5K$16.00+$3.00M+7.1%2.83M after